---
project-name: "On-Device ML Health Monitoring Wearable"
session-dir: "test-runs/wearable-device/high"
datetime: 2026-04-28
effort: "high"
stage: "Phase 3: Multi-Perspective Brainstorming"
model-requested: "haiku"
model-reported: "claude-haiku-4-5-20251001"
topic-cluster: "01_foundational-premises-and-first-principles-reframings"
persona: "The Pragmatist"
---

# Foundational Premises and First-Principles Reframings - The Pragmatist

---

## Q1: Detection vs. Confirmation and Wrist Signal Quality

* **Summary.** The wrist-as-deployment-site is a resource-constrained choice, not a technical mandate. A practical path forward starts with honest signal-quality benchmarking: measure PPG SNR, motion-artifact floor, and AFib detection sensitivity *at the wrist* against gold-standard devices (chest straps, finger probes) using your target 40+ cohort in realistic settings (sleep, daily activity). Once you have those baselines, decide whether the wrist alone is viable or if you need a dual-sensor ecosystem (wrist + occasional chest-band confirmations). The "confirming normalcy" angle is strategically sound: instead of designing for borderline arrhythmia calls, build confidence intervals around normal rhythms and flag only *clear* deviations. This also reduces liability exposure—you're not claiming to diagnose, you're proving you can rule out red flags. Budget 3 months for a limited-cohort SNR study before committing to the full model stack.

---

## Q2: Information-Theoretic Minimum Model and Sensor Independence

* **Summary.** Start with a decision-tree audit: build a shallow tree (depth ≤5) using the PPG and accelerometer alone against your labeled AFib dataset, measure accuracy, then add each sensor channel one at a time and track the marginal improvement. My prediction: you'll hit 85–90% of your discriminative power with just PPG and motion-acceleration, making the temperature and microphone candidates for duty-cycling. Once you know which subset justifies its power cost, you can drop the NPU requirement entirely if a lookup table or ensemble of small trees outperforms it. This also shrinks your firmware footprint and reduces hardware risk. Practically: do this analysis in the next 6 weeks using existing datasets (MIT-BIH arrhythmia, ICBEB) before you finalize the sensor stack. If a simple model wins, you've just freed up 8 weeks of firmware integration and saved several hundred milliamps per day.

---

## Q3: Microphone Signal Validation

* **Summary.** The microphone is your riskiest sensor from both regulatory and privacy angles—and it's not yet justified. A pragmatic validation approach: partition your sleep-apnea dataset into a PPG-plus-accel subset and a full-sensor subset, train parallel models, and measure AUC-ROC or sensitivity/specificity gap. If the gap is <3–5 percentage points, drop the mic and save 15–20 mW of power. If it's >10 points, then you have a business case to defend the privacy tradeoff and invest in on-device audio processing (not streaming, not even storing snippets—just real-time feature extraction). Do this A/B test now, before hardware design locks in the microphone footprint. If the mic stays, budget 4 months for privacy-preserving audio pipeline design and legal review. If it goes, you've simplified your regulatory story and reduced your HIPAA audit surface.

---

## Q4: Personal-Signature Baseline and Continuous Adaptation

* **Summary.** This is operationally sound but requires a phased rollout. In early versions (Months 1–6 post-launch), use population-level baselines (what normal AFib thresholds look like across your 40+ cohort) and conservative alert thresholds to avoid false positives while you build confidence. Then, after 6–12 months of wear-time telemetry from early users, introduce personalized baselines: the device learns *your* rhythm characteristics and adapts detection thresholds to your personal norm. This two-phase approach manages regulatory risk (you have a defensible, population-tested starting point) and user confidence (the device becomes more attuned to you over time). The information-theoretic win is real—you'll lower false-positive rates significantly—but don't try to start with pure personalization on day one. Practically: schedule personalization for Phase 2 of development, starting around Month 8, once you have real-world data to calibrate against.

---

## Q5: Bidirectional Device-Body Coregulation

* **Summary.** This is philosophically rich but practically premature. Before you pursue "embodied awareness," answer a narrower question: what's the smallest bidirectional loop you can implement with your current hardware and timeline that delivers measurable user value? For example: the device detects elevated stress (heart-rate variability, skin temperature) and vibrates a haptic pattern that prompts breathing exercises, then monitors if your physiology calms in response. That's coregulation at scale. You could prototype this in 8 weeks using existing wearable APIs and test it with a cohort of 30 users to measure engagement and physiological effect. If it works, you've got a concrete product feature that positions the device as an active partner, not a passive monitor. If it doesn't, you've learned that bidirectionality needs more sophistication than haptics. Start small, measure signal, then expand. Avoid framing this as a philosophical shift until you have evidence it moves the needle for users and regulators accept it.
